AHCL Share Price | Anlon Healthcare Ltd Stock Analysis & Recommendation

Q: When is the next results date for Anlon Healthcare Ltd?

The next results date for Anlon Healthcare Ltd is scheduled for 09 February 2026.

Q: Why is Anlon Healthcare Ltd falling/rising?

As of 31-May, Anlon Healthcare Ltd's stock price is currently at 13.98, reflecting a decrease of 0.25, or 1.76%. The stock has underperformed its sector today by 0.27% and has experienced a trend reversal, falling after two consecutive days of gains. Despite this decline, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive long-term trend.In terms of investor activity, there has been a notable increase in delivery volume, which rose by 17.74% against the 5-day average, suggesting rising investor participation. However, the stock's year-to-date performance shows a decline of 7.63%, which is better than the Sensex's decline of 12.26%, indicating that while the stock is falling, it is doing so at a slower rate compared to the broader market.Overall, the combination of a recent price drop, underperformance against the sector, and the trend reversal after previous gains contributes to the current decline in Anlon Healthcare Ltd's stock price.

Q: Should I buy, sell or hold Anlon Healthcare Ltd?

Based on the current situation of Anlon Healthcare Ltd, it would be advisable to hold your position in the company. The low Debt to EBITDA ratio of 1.81 indicates a strong ability to service debt, which is a positive sign for financial stability. Additionally, the company has demonstrated healthy long-term growth, with net sales increasing at an impressive annual rate of 65.60%.The positive results from the last two consecutive quarters, including a higher profit after tax of Rs 24.26 crore and record net sales of Rs 55.42 crore, further support the notion of holding. However, the company's valuation appears to be on the expensive side, with a Price to Book Value ratio of 3.4, and the return on equity (ROE) of 13 suggests that while the company is performing well, it may not be the best time to buy at current prices.Moreover, the lack of investment from domestic mutual funds, which hold 0% of the company, could indicate a level of caution regarding its valuation or business prospects. Given these factors, holding your investment seems to be the most prudent course of action for now.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

13.2 lacs (-63.64%) Volume

Shareholding (Mar 2026)

FII

0.32%

Held by 5 FIIs

DII

4.60%

Held by 1 DIIs

Promoter

52.68%

When is the next results date for Anlon Healthcare Ltd?

04-Feb-2026

The next results date for Anlon Healthcare Ltd is 09 February 2026.

View full answer

Why is Anlon Healthcare Ltd falling/rising?

01-Jun-2026

As of 31-May, Anlon Healthcare Ltd's stock price is at 13.98, down 1.76%, and has underperformed its sector. Despite a recent decline, the stock remains above key moving averages and has seen increased investor activity, although it has a year-to-date decline of 7.63%, better than the broader market's performance.

View full answer

Which are the latest news on Anlon Healthcare?

01-Jun-2026

No latest news for Anlon Healthcare found.

Should I buy, sell or hold Anlon Healthcare Ltd?

02-Jun-2026

Compare Anlon Healthcare with Similar Stocks

Anuh Pharma Kilitch Drugs Sigachi Indust.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 0

Healthy long term growth as Net Sales has grown by an annual rate of 65.60% and Operating profit at 0%

The company has declared Positive results for the last 2 consecutive quarters

With ROE of 13, it has a Very Expensive valuation with a 3.4 Price to Book Value

Despite the size of the company, domestic mutual funds hold only 0% of the company

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 731 Cr (Micro Cap)

P/E

26.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.07

Return on Equity

9.57%

Price to Book

3.44

Revenue and Profits:

Net Sales:

51 Cr

(Quarterly Results - Mar 2026)

Net Profit:

10 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

25.25%

6 Months

-18.08%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Anlon Healthcare Q4 FY26: Strong Profit Rebound Masks Margin Pressure and Valuation Concerns

Anlon Healthcare Ltd. delivered a robust profit recovery in Q4 FY26, posting consolidated net profit of ₹10.50 crores, marking a dramatic 103.88% sequential surge from the preceding quarter's ₹5.15 crores. The micro-cap pharmaceutical company, with a market capitalisation of ₹731.00 crores, demonstrated strong topline momentum as net sales climbed 43.03% quarter-on-quarter to ₹50.89 crores, though operating margins contracted to 30.05% from 34.49% in Q3 FY26. The stock closed at ₹13.59 on June 1, 2026, down 2.79% from the previous session, reflecting cautious investor sentiment despite the headline profit growth.

Read full news article

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication

30-May-2026 | Source : BSE

Copy of newspaper publication dated May 30 2026 regarding publication of extract of Audited Financial Results (Standalone and Consolidated) for Quarter and Year ended 31st March 2026.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

30-May-2026 | Source : BSE

Intimation for Press Release of Audited Financial Results (Standalone and Consolidated) for the Quarter and Year ended March 31 2026.

Board Meeting Outcome for To Consider And Approve Financial Results For The Quarter And Year Ended March 31 2026

29-May-2026 | Source : BSE

We have attached herewith outcome of Board Meeting held on Friday May 29 2026. Kindly take the same on your record. Thank you.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

Anlon Healthcare Ltd has announced 2:10 stock split, ex-date: 24 Apr 26

BONUS

Anlon Healthcare Ltd has announced 1:1 bonus issue, ex-date: 24 Apr 26

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

65.60%

EBIT Growth (5y)

58.45%

EBIT to Interest (avg)

9.24

Debt to EBITDA (avg)

2.57

Net Debt to Equity (avg)

0.70

Sales to Capital Employed (avg)

0.86

Tax Ratio

31.64%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

4.92%

ROCE (avg)

9.07%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.38

EV to EBIT

16.50

EV to EBITDA

16.02

EV to Capital Employed

3.23

EV to Sales

4.19

PEG Ratio

Dividend Yield

ROCE (Latest)

19.57%

ROE (Latest)

12.98%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

KST

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 5 FIIs (0.32%)

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Shree Dwarikadhish Ventures Llp (7.53%)

Individual Investors Holdings

24.38%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 55.76% vs -31.84% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 90.10% vs -44.74% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "55.42",
          "val2": "35.58",
          "chgp": "55.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.91",
          "val2": "12.27",
          "chgp": "13.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.18",
          "val2": "1.51",
          "chgp": "-21.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.79",
          "val2": "5.15",
          "chgp": "90.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.10%",
          "val2": "34.49%",
          "chgp": "-9.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "85.50",
          "val2": "62.00",
          "chgp": "37.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.98",
          "val2": "14.45",
          "chgp": "38.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.68",
          "val2": "1.91",
          "chgp": "-12.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "12.86",
          "val2": "6.36",
          "chgp": "102.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.37%",
          "val2": "23.31%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "121.08",
          "val2": "71.36",
          "chgp": "69.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.25",
          "val2": "15.03",
          "chgp": "114.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.19",
          "val2": "2.80",
          "chgp": "13.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "18.01",
          "val2": "3.87",
          "chgp": "365.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.64%",
          "val2": "21.06%",
          "chgp": "5.58%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "176.50",
          "val2": "120.29",
          "chgp": "46.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.14",
          "val2": "32.21",
          "chgp": "43.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.35",
          "val2": "3.72",
          "chgp": "16.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "27.81",
          "val2": "20.52",
          "chgp": "35.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.14%",
          "val2": "26.78%",
          "chgp": "-0.64%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

55.42

35.58

55.76%

Operating Profit (PBDIT) excl Other Income

13.91

12.27

13.37%

Interest

1.18

1.51

-21.85%

Exceptional Items

0.00

Standalone Net Profit

9.79

5.15

90.10%

Operating Profit Margin (Excl OI)

25.10%

34.49%

-9.39%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 55.76% vs -31.84% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 90.10% vs -44.74% in Dec 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

85.50

62.00

37.90%

Operating Profit (PBDIT) excl Other Income

19.98

14.45

38.27%

Interest

1.68

1.91

-12.04%

Exceptional Items

0.00

Standalone Net Profit

12.86

6.36

102.20%

Operating Profit Margin (Excl OI)

23.37%

23.31%

0.06%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

121.08

71.36

69.67%

Operating Profit (PBDIT) excl Other Income

32.25

15.03

114.57%

Interest

3.19

2.80

13.93%

Exceptional Items

0.00

Standalone Net Profit

18.01

3.87

365.37%

Operating Profit Margin (Excl OI)

26.64%

21.06%

5.58%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

176.50

120.29

46.73%

Operating Profit (PBDIT) excl Other Income

46.14

32.21

43.25%

Interest

4.35

3.72

16.94%

Exceptional Items

0.00

Standalone Net Profit

27.81

20.52

35.53%

Operating Profit Margin (Excl OI)

26.14%

26.78%

-0.64%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Anlon Healthcare Ltd

Anlon Healthcare Ltd

Micro Cap

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available